Tezspire lowered inflammation in the esophagus.
Swallowing difficulty improved for participants.
The trial compared Tezspire to a placebo (a fake pill).
The drug is already approved for severe asthma.
The result is good news after other recent trial setbacks.
People who used the medicine found it easier to swallow compared with a harmless sugar pill. 😊
The study was a late‑stage test, meaning many people took part to see if it works well. 📊
This success gives hope after some recent medicines did not work as expected. 🌟
Want to learn even more? Click here to read the full story!